Authors:
Favelyukis, S
Till, JH
Hubbard, SR
Miller, WT
Citation: S. Favelyukis et al., Structure and autoregulation of the insulin-like growth factor 1 receptor kinase, NAT ST BIOL, 8(12), 2001, pp. 1058-1063
Authors:
Till, JH
Ablooglu, AJ
Frankel, M
Bishop, SM
Kohanski, RA
Hubbard, SR
Citation: Jh. Till et al., Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase - Insights into kinase mechanism, J BIOL CHEM, 276(13), 2001, pp. 10049-10055
Citation: Eg. Stein et al., The BPS domain of Grb10 inhibits the catalytic activity of the insulin andIGF1 receptors, FEBS LETTER, 493(2-3), 2001, pp. 106-111
Authors:
Plotnikov, AN
Hubbard, SR
Schlessinger, J
Mohammadi, M
Citation: An. Plotnikov et al., Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity, CELL, 101(4), 2000, pp. 413-424
Authors:
Ablooglu, AJ
Till, JH
Kim, K
Parang, K
Cole, PA
Hubbard, SR
Kohanski, RA
Citation: Aj. Ablooglu et al., Probing the catalytic mechanism of the insulin receptor kinase with a tetrafluorotyrosine-containing peptide substrate, J BIOL CHEM, 275(39), 2000, pp. 30394-30398
Authors:
Laird, AD
Vajkoczy, P
Shawver, LK
Thurnher, A
Liang, C
Mohammadi, M
Schlessinger, J
Ullrich, A
Hubbard, SR
Blake, RA
Fong, TAT
Strawn, LM
Sun, L
Tang, C
Hawtin, R
Tang, F
Shenoy, N
Hirth, KP
McMahon, G
Cherrington, JM
Citation: Ad. Laird et al., SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors, CANCER RES, 60(15), 2000, pp. 4152-4160
Authors:
Nelms, K
O'Neill, TJ
Li, SQ
Hubbard, SR
Gustafson, TA
Paul, WE
Citation: K. Nelms et al., Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain, MAMM GENOME, 10(12), 1999, pp. 1160-1167
Authors:
Mandiyan, V
Andreev, J
Schlessinger, J
Hubbard, SR
Citation: V. Mandiyan et al., Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta, EMBO J, 18(24), 1999, pp. 6890-6898